Literature DB >> 16436673

CSR1 suppresses tumor growth and metastasis of prostate cancer.

Guoying Yu1, George C Tseng, Yan Ping Yu, Tim Gavel, Joel Nelson, Alan Wells, George Michalopoulos, Demetrius Kokkinakis, Jian-Hua Luo.   

Abstract

Prostate cancer is frequent among men over 45 years of age, but it generally only becomes lethal with metastasis. In this study, we identified a gene called cellular stress response 1 (CSR1) that was frequently down-regulated and methylated in prostate cancer samples. Survival analysis indicated that methylation of the CSR1 promoter, and to a lesser extent down-regulation of CSR1 protein expression, was associated with a high rate of prostate cancer metastasis. Forced expression of CSR1 in prostate cancer cell lines DU145 and PC3 resulted in a two- to threefold decrease in colony formation and a 10-fold reduction in anchorage-independent growth. PC3 cells stably expressing CSR1 had an average threefold decrease in their ability to invade in vitro. Expression of CSR1 in PC3 cell xenografts produced a dramatic reduction (>8-fold) in tumor size, rate of invasion (0 versus 31%), and mortality (13 versus 100%). The present findings suggest that CSR1 is a potent tumor sup-pressor gene.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16436673      PMCID: PMC1606498          DOI: 10.2353/ajpath.2006.050620

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  16 in total

1.  Gene expression analysis of prostate cancers.

Authors:  Jian-Hua Luo; Yan Ping Yu; Kathleen Cieply; Fan Lin; Petrina Deflavia; Rajiv Dhir; Sydney Finkelstein; George Michalopoulos; Michael Becich
Journal:  Mol Carcinog       Date:  2002-01       Impact factor: 4.784

2.  Cancer statistics, 2005.

Authors:  Ahmedin Jemal; Taylor Murray; Elizabeth Ward; Alicia Samuels; Ram C Tiwari; Asma Ghafoor; Eric J Feuer; Michael J Thun
Journal:  CA Cancer J Clin       Date:  2005 Jan-Feb       Impact factor: 508.702

3.  DBC2, a candidate for a tumor suppressor gene involved in breast cancer.

Authors:  Masaaki Hamaguchi; Jennifer L Meth; Christine von Klitzing; Wen Wei; Diane Esposito; Linda Rodgers; Tom Walsh; Piri Welcsh; Mary-Claire King; Michael H Wigler
Journal:  Proc Natl Acad Sci U S A       Date:  2002-10-07       Impact factor: 11.205

4.  Homozygous deletion and frequent allelic loss of chromosome 8p22 loci in human prostate cancer.

Authors:  G S Bova; B S Carter; M J Bussemakers; M Emi; Y Fujiwara; N Kyprianou; S C Jacobs; J C Robinson; J I Epstein; P C Walsh
Journal:  Cancer Res       Date:  1993-09-01       Impact factor: 12.701

5.  Gene expression alterations in prostate cancer predicting tumor aggression and preceding development of malignancy.

Authors:  Yan Ping Yu; Douglas Landsittel; Ling Jing; Joel Nelson; Baoguo Ren; Lijun Liu; Courtney McDonald; Ryan Thomas; Rajiv Dhir; Sydney Finkelstein; George Michalopoulos; Michael Becich; Jian-Hua Luo
Journal:  J Clin Oncol       Date:  2004-07-15       Impact factor: 44.544

6.  DLC-1 operates as a tumor suppressor gene in human non-small cell lung carcinomas.

Authors:  Bao-Zhu Yuan; Amy M Jefferson; Kimberly T Baldwin; Snorri S Thorgeirsson; Nicholas C Popescu; Steven H Reynolds
Journal:  Oncogene       Date:  2004-02-19       Impact factor: 9.867

7.  Genetic and epigenetic alterations of DLC-1 gene in hepatocellular carcinoma.

Authors:  Chun-Ming Wong; Joyce Man-Fong Lee; Yick-Pang Ching; Dong-Yan Jin; Irene Oi-lin Ng
Journal:  Cancer Res       Date:  2003-11-15       Impact factor: 12.701

8.  DLC-1 gene inhibits human breast cancer cell growth and in vivo tumorigenicity.

Authors:  Bao-Zhu Yuan; Xiaoling Zhou; Marian E Durkin; Drazen B Zimonjic; Katrin Gumundsdottir; Jorunn E Eyfjord; Snorri S Thorgeirsson; Nicholas C Popescu
Journal:  Oncogene       Date:  2003-01-23       Impact factor: 9.867

9.  The CpG island searcher: a new WWW resource.

Authors:  Daiya Takai; Peter A Jones
Journal:  In Silico Biol       Date:  2003

Review 10.  Genetic factors underlying prostate cancer.

Authors:  Jian-Hua Luo; Yan Ping Yu
Journal:  Expert Rev Mol Med       Date:  2003-04-15       Impact factor: 5.600

View more
  30 in total

1.  CSR1 induces cell death through inactivation of CPSF3.

Authors:  Z-H Zhu; Y P Yu; Y-K Shi; J B Nelson; J-H Luo
Journal:  Oncogene       Date:  2008-09-22       Impact factor: 9.867

2.  Matrix metalloproteinase-19 promotes metastatic behavior in vitro and is associated with increased mortality in non-small cell lung cancer.

Authors:  Guoying Yu; Jose D Herazo-Maya; Tomoko Nukui; Marjorie Romkes; Anil Parwani; Brenda M Juan-Guardela; Jennifer Robertson; Jack Gauldie; Jill M Siegfried; Naftali Kaminski; Daniel J Kass
Journal:  Am J Respir Crit Care Med       Date:  2014-10-01       Impact factor: 21.405

3.  Whole-genome methylation sequencing reveals distinct impact of differential methylations on gene transcription in prostate cancer.

Authors:  Yan P Yu; Ying Ding; Rui Chen; Serena G Liao; Bao-Guo Ren; Amantha Michalopoulos; George Michalopoulos; Joel Nelson; George C Tseng; Jian-Hua Luo
Journal:  Am J Pathol       Date:  2013-10-08       Impact factor: 4.307

4.  Multifaceted preventive effects of single agent quercetin on a human prostate adenocarcinoma cell line (PC-3): implications for nutritional transcriptomics and multi-target therapy.

Authors:  Mohammad R Noori-Daloii; Majid Momeny; Mehdi Yousefi; Forough Golsaz Shirazi; Mehdi Yaseri; Nasrin Motamed; Nazanin Kazemialiakbar; Saeed Hashemi
Journal:  Med Oncol       Date:  2010-07-02       Impact factor: 3.064

5.  Integrin α7 binds tissue inhibitor of metalloproteinase 3 to suppress growth of prostate cancer cells.

Authors:  Lang-Zhu Tan; Yang Song; Joel Nelson; Yan P Yu; Jian-Hua Luo
Journal:  Am J Pathol       Date:  2013-07-02       Impact factor: 4.307

6.  MAN2A1-FER Fusion Gene Is Expressed by Human Liver and Other Tumor Types and Has Oncogenic Activity in Mice.

Authors:  Zhang-Hui Chen; Yan P Yu; Junyan Tao; Silvia Liu; George Tseng; Michael Nalesnik; Ronald Hamilton; Rohit Bhargava; Joel B Nelson; Arjun Pennathur; Satdarshan P Monga; James D Luketich; George K Michalopoulos; Jian-Hua Luo
Journal:  Gastroenterology       Date:  2017-02-27       Impact factor: 22.682

7.  Genome-wide methylation analysis of prostate tissues reveals global methylation patterns of prostate cancer.

Authors:  Jian-Hua Luo; Ying Ding; Rui Chen; George Michalopoulos; Joel Nelson; George Tseng; Yan P Yu
Journal:  Am J Pathol       Date:  2013-04-10       Impact factor: 4.307

8.  Scavenger receptor class A member 3 (SCARA3) in disease progression and therapy resistance in multiple myeloma.

Authors:  Charles O Brown; Jeanine Schibler; Matthew P Fitzgerald; Neeraj Singh; Kelley Salem; Fenghuang Zhan; Apollina Goel
Journal:  Leuk Res       Date:  2013-03-26       Impact factor: 3.156

9.  Selenite reactivates silenced genes by modifying DNA methylation and histones in prostate cancer cells.

Authors:  Nong Xiang; Rui Zhao; Guoqing Song; Weixiong Zhong
Journal:  Carcinogenesis       Date:  2008-08-01       Impact factor: 4.944

10.  Metallothionein 1 h tumour suppressor activity in prostate cancer is mediated by euchromatin methyltransferase 1.

Authors:  Yu-Chen Han; Zhong-Liang Zheng; Ze-Hua Zuo; Yan P Yu; Rui Chen; George C Tseng; Joel B Nelson; Jian-Hua Luo
Journal:  J Pathol       Date:  2013-06       Impact factor: 7.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.